CTLA4 and neoplasm: Proinflammatory cytokines (TNF-α, IL-β, and IL-23) released by M2-type TAMs in solid tumors continue induce overexpression of PD-L1, CTLA4, and glucocorticoid-induced TNF receptor family-regulated protein (GITR) to inhibit tumor immunity57.